Clinical Trials Directory

Trials / Completed

CompletedNCT01409304

Effectiveness of Deep Transcranial Magnetic Stimulation in Depression

Effectiveness of Deep Transcranial Magnetic Stimulation for Treating Major Depression: a Pilot Study

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Douglas Mental Health University Institute · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

We intend to investigate whether deep transcranial magnetic stimulation (DTMS), a novel brain stimulation technique, is effective for treating major depression. We hypothesize that 4 weeks of DTMS will be associated with significant improvements in depressive and anxious symptoms without significant side effects.

Detailed description

The aim of this pilot study is to assess, naturalistically, the effectiveness of deep transcranial magnetic stimulation (DTMS) in a sample of subjects with treatment-resistant depression. To do this, enrolled depressed outpatients will be assigned to receive 4 weeks of daily DTMS and will be evaluated at baseline and during week 5. We hypothesize that treatment with DTMS will be associated with significant clinical improvements in depressive and anxious symptoms, and will be well tolerated.

Conditions

Interventions

TypeNameDescription
DEVICEDeep Transcranial Magnetic Stimulation (DTMS)DTMS will be administered according to the following parameters: 18 Hz in 84 trains of 2 seconds duration, with 20 seconds inter-train interval (3,024 pulses per session) at 120% of the resting motor threshold.

Timeline

Start date
2011-10-01
Primary completion
2012-12-01
Completion
2012-12-01
First posted
2011-08-04
Last updated
2013-01-18

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01409304. Inclusion in this directory is not an endorsement.